Insider Transactions in Q2 2024 at Outset Medical, Inc. (OM)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2024
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
10,569
-4.33%
|
$42,276
$4.78 P/Share
|
|
Jun 03
2024
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
38,117
-24.63%
|
$114,351
$3.77 P/Share
|
|
Jun 03
2024
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69,303
+30.18%
|
$69,303
$1.11 P/Share
|
|
May 29
2024
|
Dale E Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+35.25%
|
-
|
|
May 29
2024
|
Brent D. Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+15.82%
|
-
|
|
May 29
2024
|
Andrea Lynn Saia Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+34.3%
|
-
|
|
May 29
2024
|
Patrick T Hackett Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+36.85%
|
-
|
|
May 29
2024
|
James F. Hinrichs Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+23.73%
|
-
|
|
May 29
2024
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+34.14%
|
-
|
|
May 29
2024
|
D Keith Grossman Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+36.85%
|
-
|
|
May 16
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,918
-1.21%
|
$11,754
$3.53 P/Share
|
|
May 16
2024
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
2,972
-1.2%
|
$8,916
$3.53 P/Share
|
|
May 16
2024
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
1,097
-0.45%
|
$3,291
$3.53 P/Share
|
|
May 16
2024
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,237
-0.57%
|
$15,711
$3.53 P/Share
|
|
May 10
2024
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
8,306
-3.04%
|
$24,918
$3.27 P/Share
|